Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene

Graefes Arch Clin Exp Ophthalmol. 2002 Oct;240(10):822-8. doi: 10.1007/s00417-002-0562-z. Epub 2002 Sep 21.

Abstract

Purpose: To describe the clinical phenotype of the complete type of X-linked congenital stationary night blindness (CSNB1) with different types of mutations in the NYX gene.

Methods: The clinical and genetic data from 18 male patients with eight different mutations from two ophthalmological institutes were reviewed. The variability in refractive error, reduced visual acuity and full-field electroretinogram (ERG) recordings was examined.

Results: Parameters were quantitatively analyzed based on the classification of mutations according to their predicted effect on protein structure and function. CSNB1 patients with mutations changing structurally conserved residues ( n=12) tended to have a lower degree of myopia than patients with mutations of non-conserved residues ( n=6). Visual acuity loss and the 30 Hz flicker ERG recordings were similar in the two groups. Values for the b/a amplitude ratio tended to be clustered in patients carrying the same mutation. Refractive error and the b/a amplitude ratio were highly correlated between the two eyes of an individual.

Conclusions: These data suggest correlations between phenotypic expression in CSNB1 and individual genotypes as well as class types of mutations based on the extent of structural amino acid conservation. A high inter-eye correlation suggests that other genetic or environmental factors, rather than chance, play a part in determining the phenotypic diversity in CSNB1.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amino Acid Sequence / genetics
  • Chromosomes, Human, X*
  • Conserved Sequence
  • Electroretinography
  • Genetic Linkage*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Myopia / genetics
  • Myopia / physiopathology
  • Night Blindness / genetics*
  • Night Blindness / physiopathology
  • Phenotype
  • Proteoglycans / genetics*
  • Retrospective Studies
  • Visual Acuity

Substances

  • NYX protein, human
  • Proteoglycans